Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Growth

    Back to All Ratios
VALIANT LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) -40.72-96.81-

What is the latest Core EBITDA Growth ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Growth ratio of VALIANT LABORATORIES is -40.72 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-40.72
Mar2024-96.81
Mar2023-

How is Core EBITDA Growth of VALIANT LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -40.72
Negative
Mar2024 -96.81
0
Mar2023 0 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Growth ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹353.0 Cr -3.2% -17.8% -34.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,593.0 Cr 2.7% 7.5% 12.8% Stock Analytics
DIVIS LABORATORIES ₹179,737.0 Cr 4.2% 3.9% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹164,290.0 Cr 4.3% 11.2% 42.5% Stock Analytics
CIPLA ₹117,327.0 Cr 0.4% 5.3% -3% Stock Analytics
DR REDDYS LABORATORIES ₹112,994.0 Cr 0.9% 8% 5.6% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-3.2%

-17.8%

-34.1%

SENSEX

2.2%

5.1%

-7%


You may also like the below Video Courses